Log in
NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast, Price & News

$40.99
+1.01 (+2.53 %)
(As of 10/22/2020 12:00 AM ET)
Add
Today's Range
$40.25
Now: $40.99▼
$40.99
50-Day Range
$37.46
MA: $40.28▼
$43.51
52-Week Range
$23.00
Now: $40.99▼
$45.70
Volume4,418 shs
Average Volume30,517 shs
Market Capitalization$38.94 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of BBC

Currency Exposure of BBC

Sector Exposure of BBC

Industry Exposure of BBC

Basic Details

Issuer Virtus
Fund NameVirtus LifeSci Biotech Clinical Trials ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BBC
Inception Date12/16/2014
Fund ManagerMatthew B. Brown, Seth Kadushin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkLifeSci Biotechnology Clinical Trials Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$42.79 million
Average Daily Volume$15,843.10
Discount/Premium-0.05%

ETF Expenses

Management Fee0.79%
Other Expenses0.00%
Total Expenses0.79%
Fee Waiver0.00%
Net Expenses0.79%

Administrator, Advisor and Custodian

AdministratorVirtus ETF Solutions, LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial
$40.99
+1.01 (+2.53 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BBC News and Ratings via Email

Sign-up to receive the latest news and ratings for BBC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Frequently Asked Questions

How has Virtus LifeSci Biotech Clinical Trials ETF's stock price been impacted by COVID-19?

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $30.11 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BBC shares have increased by 36.1% and is now trading at $40.9883.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Sanofi (SNY), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ).

What is Virtus LifeSci Biotech Clinical Trials ETF's stock symbol?

Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BBC."

How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF?

Shares of BBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today?

One share of BBC stock can currently be purchased for approximately $40.99.

How big of a company is Virtus LifeSci Biotech Clinical Trials ETF?

Virtus LifeSci Biotech Clinical Trials ETF has a market capitalization of $38.94 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.